This protection from anaphylaxis was associated with a significant decrease of OVA-specific IgE levels (Figure 8B) and a decrease in cytokine response by in vitro re-stimulated splenocytes (Figures 8C–E) from EPIT-treated mice compared to untreated controls. This evidence concerns the gene IGHE and anaphylaxis.